Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays
出版年份 2023 全文链接
标题
Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays
作者
关键词
-
出版物
PHARMACEUTICAL RESEARCH
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-26
DOI
10.1007/s11095-023-03625-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Binding and neutralizing anti-AAV antibodies: Detection and implications for rAAV-mediated gene therapy
- (2023) Martin Schulz et al. MOLECULAR THERAPY
- Comparison of Pre-existing Anti-AAV8 Total Antibody Screening and Confirmatory Assays with a Cell-Based Neutralizing Assay in Normal Human Serum
- (2023) Yanshan Dai et al. AAPS Journal
- Various AAV Serotypes and Their Applications in Gene Therapy: An Overview
- (2023) Shaza S. Issa et al. Cells
- Testing preexisting antibodies prior to AAV gene transfer therapy: rationale, lessons and future considerations
- (2022) Jerry R. Mendell et al. Molecular Therapy-Methods & Clinical Development
- Clinical enrollment assay to detect preexisting neutralizing antibodies to AAV6 with demonstrated transgene expression in gene therapy trials
- (2022) Liching Cao et al. GENE THERAPY
- Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper
- (2022) Tong-yuan Yang et al. Molecular Therapy-Methods & Clinical Development
- AAVrh10 vector corrects pathology in animal models of GM1 gangliosidosis and achieves widespread distribution in the CNS of nonhuman primates
- (2022) Michaël Hocquemiller et al. Molecular Therapy-Methods & Clinical Development
- Anti-AAV Antibodies in AAV Gene Therapy: Current Challenges and Possible Solutions
- (2021) Thomas Weber Frontiers in Immunology
- Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
- (2021) Wei Zhan et al. Frontiers in Immunology
- Adeno-associated virus serotype 9 antibodies in patients screened for treatment with onasemnogene abeparvovec
- (2021) John W. Day et al. Molecular Therapy-Methods & Clinical Development
- Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody Assays
- (2020) Boris Gorovits et al. AAPS Journal
- AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
- (2020) Helena Costa Verdera et al. MOLECULAR THERAPY
- Intra-CSF AAV9 and AAVrh10 Administration in Nonhuman Primates: Promising Routes and Vectors for Which Neurological Diseases?
- (2020) Karim Bey et al. Molecular Therapy-Methods & Clinical Development
- Quantitative Whole-Body Imaging of I-124-Labeled Adeno-Associated Viral Vector Biodistribution in Nonhuman Primates
- (2020) Douglas J. Ballon et al. HUMAN GENE THERAPY
- Current Clinical Applications of In Vivo Gene Therapy with AAVs
- (2020) Jerry R. Mendell et al. MOLECULAR THERAPY
- Adeno-associated virus vector as a platform for gene therapy delivery
- (2019) Dan Wang et al. NATURE REVIEWS DRUG DISCOVERY
- Therapeutic hFIX activity achieved after single AAV5-hFIX treatment in hemophilia B patients and NHPs with pre-existing anti-AAV5 NABs
- (2019) Anna Majowicz et al. Molecular Therapy-Methods & Clinical Development
- From Clinical Trials to Clinical Practice: Practical Considerations for Gene Replacement Therapy in SMA Type 1
- (2019) Samiah A. Al-Zaidy et al. PEDIATRIC NEUROLOGY
- The adeno-associated virus rh10 vector is an effective gene transfer system for chronic spinal cord injury
- (2019) Yutaka Hoshino et al. Scientific Reports
- The rapidly evolving state of gene therapy
- (2018) Alisha M. Gruntman et al. FASEB JOURNAL
- AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease
- (2018) Jonathan B. Rosenberg et al. Human Gene Therapy Clinical Development
- Development of a Chemiluminescent ELISA Method for the Detection of Total Anti-Adeno Associated Virus Serotype 9 (AAV9) Antibodies
- (2018) Uma Kavita et al. Human Gene Therapy Methods
- Strategy to detect pre-existing immunity to AAV gene therapy
- (2017) L Falese et al. GENE THERAPY
- From the bench to clinical practice: understanding the challenges and uncertainties in immunogenicity testing for biopharmaceuticals
- (2016) G. R. Gunn et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD)
- (2015) Klaudia Kawecka et al. CURRENT GENE THERAPY
- Systemic AAVrh10 provides higher transgene expression than AAV9 in the brain and the spinal cord of neonatal mice
- (2015) Yannick Tanguy et al. Frontiers in Molecular Neuroscience
- AAVrh.10 immunogenicity in mice and humans. Relevance of antibody cross-reactivity in human gene therapy
- (2014) R Thwaite et al. GENE THERAPY
- Transduction efficiency of neurons and glial cells by AAV-1, -5, -9, -rh10 and -hu11 serotypes in rat spinal cord following contusion injury
- (2014) H A Petrosyan et al. GENE THERAPY
- Intracerebral Administration of Adeno-Associated Viral Vector Serotype rh.10 Carrying Human SGSH and SUMF1 cDNAs in Children with Mucopolysaccharidosis Type IIIA Disease: Results of a Phase I/II Trial
- (2014) Marc Tardieu et al. HUMAN GENE THERAPY
- Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products
- (2008) Gopi Shankar et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
- (2008) Kevin D Foust et al. NATURE BIOTECHNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search